Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
81-13-0
Molecular formula
C9H19NO4
Molecular weight
205.25 g/mol
Drug class
Provitamin B5dexpanthenol-related skin-conditioning and wound-care agent
Mechanism of action
An alcoholic analogue of D-pantothenic acid that is converted to pantothenic acid and contributes to coenzyme A synthesis. Topical dexpanthenol-containing preparations support skin hydration and epithelial repair; the exact mechanism in topical use is not fully established.
Indications / reported uses
Topical use to support skin-barrier recovery and minor wound healing in authorised creams and ointments.
Dexpanthenol-containing preparations are also used for selected mucosal and gastrointestinal indications in some jurisdictions.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Pantothenol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Pantothenol Permitted Daily Exposure (PDE) report (the Pantothenol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Pantothenol Occupational Exposure Limit (OEL) report (the Pantothenol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.